Immunocytochemistry (ICC) is a laboratory technique used to visualize and quantify proteins or macromolecules present in cells. It relies on antibodies that specifically bind to target antigens, enabling researchers to study the quantity, distribution, and localization of proteins or other targets of interest within cell populations. This technique has become ubiquitous in both academic and clinical research, as it offers several benefits that contribute to our understanding of various cellular and disease mechanisms. Here’s a brief overview of some noteworthy benefits of immunocytochemistry for researchers.
1. Precise Localization of Proteins
One of the primary advantages of immunocytochemistry is its ability to determine the precise location of proteins within cells. By using fluorescent or chromogenic tags conjugated to antibodies, ICC can provide a detailed visual representation of the spatial distribution of cellular proteins and structures. Researchers generally perform localization assays with a high-resolution microscope or high-content imager. This process is essential for understanding complex cellular interactions such as signal transduction, receptor binding, and cellular compartmentalization.
For instance, researchers studying cancer cells often use immunocytochemistry to track the expression of specific biomarkers within the tumor microenvironment.[1] This helps to identify key molecular targets for potential therapeutic treatments. ICC has also been used by neuroscientists to map the distribution of neurotransmitter receptors and identify changes in protein localization characteristic of neurodegenerative diseases.[2,3]
2. Understanding Cellular Pathology
Immunocytochemistry plays a crucial role in understanding cellular pathology, particularly in the context of cancer, neurodegenerative disorders, and autoimmune diseases. It allows for the identification of abnormal protein expression patterns that are often indicative of disease. In cancer research, ICC can detect overexpression of oncogenes or abnormal cellular accumulation associated with tumorigenesis.[1]
In studying neurodegenerative diseases, immunocytochemistry has been used to investigate the accumulation of plaques and tau tangles, key hallmarks of Alzheimer's disease.[2] Researchers can track how these proteins accumulate within neurons, providing insight into the disease's progression over time. ICC is also useful for examining the effects of potential therapies, as it allows researchers to monitor treatment efficacy at the cellular level.
3. Accurate Quantification of Protein Expression
Immunocytochemistry is not only useful for visualizing protein localization. It’s also beneficial for quantifying target protein expression within cells. By employing image analysis software, researchers can quantify the intensity of the signal produced by the antibody-antigen interaction, providing an accurate measure of relative protein abundance. Quantifying protein expression is critical for comparing healthy and diseased states and for assessing the effects of experimental treatments.
In studies of cellular responses to different stimuli, immunocytochemistry may also be used to assess changes in protein expression levels, offering insights into cellular signaling pathways and gene regulation. For example, ICC has been used to quantify the expression of proteins involved in immune responses, such as cytokines and transcription factors, helping researchers to better understand immune system regulation.[4]
It's also worth mentioning the benefits of the In-Cell Western™ Assay for quantifying protein expression. LICORbio scientists developed this revolutionary immunocytochemical application for Odyssey® Imaging Systems, and we continue to support it today. This quantitative cell-based immunofluorescence assay combines the specificity of Western blotting with the replicability and throughput of enzyme-linked immunosorbent assays (ELISAs). However, the In-Cell Western Assay detects proteins in situ rather than in a gel or on a membrane, providing a more relevant cellular context for quantification. This also significantly streamlines the workflow, saving researchers hours that would normally be spent on membrane transfer and blocking. Plus, the In-Cell Western Assay requires far smaller sample sizes than other protein expression assays, reducing the cost of technical and biological replicates, as well as overall assay development and optimization. For more in-depth information about the In-Cell Western Assay, please download our free In-Cell Western Assay Development Handbook.
4. Cell Type Identification and Characterization
Another important benefit of immunocytochemistry is its ability to identify and characterize different cell types based on the expression of specific biomarkers. Many cell types express unique surface or intracellular markers, and by targeting them with specific antibodies, researchers can use ICC techniques to distinguish between cell types and study their precise functions.[5]
This is especially useful in the context of stem cell research.[6] Immunocytochemistry can be used to confirm the differentiation of stem cells into specialized cell types. In immunology, this technique can detect immune cell subtypes based on the presence of specific surface proteins.[7] Researchers can then accurately map immune cell populations across different tissues and conditions using a similar technique like immunohistochemistry (IHC).
5. Applications in Drug Development and Diagnostics
Immunocytochemistry also has broad applications in drug development and diagnostics.[8] In drug discovery, it can be used to screen experimental molecules that alter the expression or localization of specific proteins, providing valuable insight into their potential therapeutic effects. ICC can also be used in preclinical studies to evaluate the efficacy of new drugs by examining changes in protein markers indicative of disease progression or regression.
In clinical diagnostics, immunocytochemistry and immunohistochemistry may be used to detect biomarkers associated with certain types of cancer.[1] Pathologists employ ICC and IHC techniques to identify cancer subtypes based on the expression of tumor markers, which can then guide and streamline treatment decisions. Finally, immunocytochemistry is crucial for identifying infectious disease pathogens by detecting pathogen-specific proteins within infected cells.
Odyssey Imaging Systems Support Immunocytochemistry
Immunocytochemistry is a comprehensive technique that allows researchers to gain a deeper understanding of cellular functions, disease mechanisms, and therapeutic treatments. The ability to visualize and quantify protein expression, identify certain cell types, and study cellular pathology makes ICC an incredibly versatile tool in both academic and applied scientific research. Whether in the study of disease, the development of new therapies, or the identification of disease-related biomarkers, the various benefits of immunocytochemistry covered here are simply the tip of the iceberg.
We’re committed to being your constant amid the uncertainty of biological research. Our Ph.D. scientists are always eager to help you optimize and troubleshoot your lab’s critical applications. If you have any questions about assay development, Odyssey Imaging Systems, or immunocytochemistry in general, please don’t hesitate to contact us today.
References
- [1] Sallam, R. M. (2015). Proteomics in cancer biomarkers discovery: Challenges and applications. Disease Markers, 2015, 1–12. https://doi.org/10.1155/2015/321370
- [2] Braak, H., et al. (2006). Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry. Acta neuropathologica, 112(4), 389–404. https://doi.org/10.1007/s00401-006-0127-z
- [3] Cuello AC, Priestley JV, Sofroniew MV. Immunocytochemistry and neurobiology. Q J Exp Physiol. 1983 Oct;68(4):545-78. doi: 10.1113/expphysiol.1983.sp002748. PMID: 6139841.
- [4] Foster J. R. (2001). The functions of cytokines and their uses in toxicology. International journal of experimental pathology, 82(3), 171–192. https://doi.org/10.1046/j.1365-2613.2001.iep0082-0171-x
- [5] Fetsch, P.A. and Abati, A. (2001). Immunocytochemistry in effusion cytology. Cancer, 93: 293-308. https://doi.org/10.1002/cncr.9044
- [6] Nethercott, H. E., Brick, D. J., & Schwartz, P. H. (2011). Immunocytochemical analysis of human pluripotent stem cells. Methods in molecular biology (Clifton, N.J.), 767, 201–220. https://doi.org/10.1007/978-1-61779-201-4_15
- [7] Margraf, A., & Perretti, M. (2022). Immune Cell Plasticity in Inflammation: Insights into Description and Regulation of Immune Cell Phenotypes. Cells, 11(11), 1824. https://doi.org/10.3390/cells11111824
- [8] Lage, O. M., Ramos, M. C., Calisto, R., Almeida, E., Vasconcelos, V., & Vicente, F. (2018). Current Screening Methodologies in Drug Discovery for Selected Human Diseases. Marine drugs, 16(8), 279. https://doi.org/10.3390/md16080279